Upexi (UPXI) Competitors $2.80 +0.10 (+3.70%) Closing price 04/15/2025 03:55 PM EasternExtended Trading$2.68 -0.13 (-4.46%) As of 04/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock UPXI vs. PHXM, ORGS, TXMD, HCWB, ATHA, NERV, TRIB, FLGC, BCDA, and CSCIShould you be buying Upexi stock or one of its competitors? The main competitors of Upexi include PHAXIAM Therapeutics (PHXM), Orgenesis (ORGS), TherapeuticsMD (TXMD), HCW Biologics (HCWB), Athira Pharma (ATHA), Minerva Neurosciences (NERV), Trinity Biotech (TRIB), Flora Growth (FLGC), BioCardia (BCDA), and COSCIENS Biopharma (CSCI). These companies are all part of the "pharmaceutical products" industry. Upexi vs. PHAXIAM Therapeutics Orgenesis TherapeuticsMD HCW Biologics Athira Pharma Minerva Neurosciences Trinity Biotech Flora Growth BioCardia COSCIENS Biopharma Upexi (NASDAQ:UPXI) and PHAXIAM Therapeutics (NASDAQ:PHXM) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Is UPXI or PHXM more profitable? Company Net Margins Return on Equity Return on Assets UpexiN/A N/A N/A PHAXIAM Therapeutics N/A N/A N/A Which has more risk and volatility, UPXI or PHXM? Upexi has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. Comparatively, PHAXIAM Therapeutics has a beta of 2.35, indicating that its share price is 135% more volatile than the S&P 500. Does the MarketBeat Community prefer UPXI or PHXM? Upexi received 3 more outperform votes than PHAXIAM Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformUpexiOutperform Votes342.86% Underperform Votes457.14% PHAXIAM TherapeuticsN/AN/A Which has higher valuation & earnings, UPXI or PHXM? PHAXIAM Therapeutics has higher revenue and earnings than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$18.63M0.20-$23.66MN/AN/APHAXIAM Therapeutics$32.66M0.32-$240KN/AN/A Does the media refer more to UPXI or PHXM? In the previous week, Upexi had 2 more articles in the media than PHAXIAM Therapeutics. MarketBeat recorded 2 mentions for Upexi and 0 mentions for PHAXIAM Therapeutics. Upexi's average media sentiment score of 1.43 beat PHAXIAM Therapeutics' score of 0.00 indicating that Upexi is being referred to more favorably in the media. Company Overall Sentiment Upexi Positive PHAXIAM Therapeutics Neutral Do insiders and institutionals have more ownership in UPXI or PHXM? 5.7% of Upexi shares are owned by institutional investors. Comparatively, 0.4% of PHAXIAM Therapeutics shares are owned by institutional investors. 34.7% of Upexi shares are owned by company insiders. Comparatively, 1.9% of PHAXIAM Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryUpexi beats PHAXIAM Therapeutics on 5 of the 9 factors compared between the two stocks. Remove Ads Get Upexi News Delivered to You Automatically Sign up to receive the latest news and ratings for UPXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPXI vs. The Competition Export to ExcelMetricUpexiMedicinals & botanicals IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.57M$1.17B$7.02B$7.57BDividend YieldN/AN/A2.69%4.32%P/E RatioN/A9.6929.7517.82Price / Sales0.207.42154.9794.61Price / CashN/A10.4031.6134.64Price / Book0.981.184.564.00Net Income-$23.66M-$56.07M$195.82M$247.23M7 Day Performance8.11%2.62%-0.27%1.45%1 Month Performance11.11%-10.00%-6.20%-6.24%1 Year Performance-71.57%-42.94%4.18%0.60% Upexi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPXIUpexi1.7955 of 5 stars$2.80+3.7%N/A-71.5%$3.57M$18.63M0.00130Short Interest ↓Gap UpPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049ORGSOrgenesisN/A$2.20-12.8%N/AN/A$10.55M$662,000.000.00150TXMDTherapeuticsMD1.1878 of 5 stars$0.90+2.2%N/A-46.7%$10.23M$1.76M0.00420HCWBHCW Biologics0.9324 of 5 stars$0.22-2.2%N/A-87.1%$9.98M$2.57M-0.2240Gap DownATHAAthira Pharma2.7495 of 5 stars$0.25-0.5%$13.83+5,462.3%-88.5%$9.71MN/A-0.0940NERVMinerva Neurosciences3.0782 of 5 stars$1.38+0.8%$5.00+262.1%-35.4%$9.66MN/A-3.149Short Interest ↑TRIBTrinity Biotech1.6876 of 5 stars$0.53-1.9%N/A-69.1%$9.57M$59.13M-0.23480Analyst ForecastPositive NewsGap DownFLGCFlora Growth2.8207 of 5 stars$0.48-2.2%$5.00+941.7%-73.6%$9.33M$59.51M-0.36280Positive NewsBCDABioCardia2.7534 of 5 stars$1.99-1.0%$25.00+1,156.3%-63.3%$9.31M$58,000.00-0.4840News CoverageGap DownCSCICOSCIENS BiopharmaN/A$2.44-4.7%N/AN/A$9.21M$7.60M-0.2120Earnings Report Remove Ads Related Companies and Tools Related Companies PHXM Alternatives ORGS Alternatives TXMD Alternatives HCWB Alternatives ATHA Alternatives NERV Alternatives TRIB Alternatives FLGC Alternatives BCDA Alternatives CSCI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPXI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upexi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upexi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPXI Stock Free UPXI Stock Alerts